Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (10)
  • Autophagy
    (6)
  • Dehydrogenase
    (3)
  • Androgen Receptor
    (2)
  • Bcr-Abl
    (2)
  • Calcium Channel
    (2)
  • DNA/RNA Synthesis
    (2)
  • Ephrin Receptor
    (2)
  • Fatty Acid Synthase
    (2)
  • Others
    (47)
Filter
Search Result
Results for "

pc3

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    94
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    9
    TargetMol | PROTAC
  • Natural Products
    13
    TargetMol | Natural_Products
  • Recombinant Protein
    20
    TargetMol | Recombinant_Protein
  • Isotope Products
    2
    TargetMol | Isotope_Products
  • Antibody Products
    9
    TargetMol | Antibody_Products
Dasatinib monohydrate
BMS-354825 Monohydrate
T1448L863127-77-9
Dasatinib monohydrate (BMS-354825 Monohydrate) is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib monohydrate binds to and inhibits the growth-promoting activities of these kinases. Apparently, because of its less stringent binding affinity for the BCR-ABL kinase, Dasatinib monohydrate has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Abacavir sulfate
Ziagen, ABC sulfate, Abacavir Hemisulfate, 1592U89
T6367188062-50-2
Abacavir sulfate (Ziagen) , a nucleoside analogue, effectively utilize its antiviral activity
  • Inquiry Price
Size
QTY
Dasatinib
BMS-354825
T1448302962-49-8
Dasatinib (BMS-354825) is an orally active, ATP-competitive tyrosine kinase inhibitor that targets Src and Bcr-Abl (Ki=16 30 pM), with antitumor activity, used in the treatment of leukemia and lymphoma.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
VPC32179
VPC-32179, VPC 32179
T35071799268-76-1
VPC32179 is a bioactive chemical.
  • Inquiry Price
Size
QTY
trpc3/6-in-1
T61407736945-96-3
TRPC3 6-IN-1 is a highly potent and selective inhibitor that blocks the activity of canonical transient receptor channels TRPC3 and TRPC6, showing significant potency against human isoforms hTRPC3 and hTRPC6 with IC50 values of 1260 nM and 500 nM, respectively. This compound is valuable for research on chronic models of heart failure [1].
  • Inquiry Price
6-8 weeks
Size
QTY
GPC3 targeting peptide 1
TP30513066113-41-2
GPC3 targeting peptide 1 binds to GPC3 with a dissociation constant (Kd) of 0.23 nM.
  • Inquiry Price
Size
QTY
Anti-GPC3 Antibody (YP7)
T9901A-176
Anti-GPC3 Antibody (YP7) is a chimeric mouse IgG1, κ antibody that specifically targets human GPC3. The recommended isotype control for Anti-GPC3 Antibody (YP7) is Mouse IgG1 kappa, Isotype Control.
  • Inquiry Price
Size
QTY
VPC32183
VPC-32183,VPC 32183
T29113717110-61-7
VPC32183 is a competitive antagonist of LPA1 and LPA3 receptors.
  • Inquiry Price
8-10 weeks
Size
QTY
TRPC3/6-IN-2
T790542387893-55-0
TRPC3 6-IN-2 is a potent inhibitor of TRPC3 and TRPC6, with IC50 values of 16 nM and 29.8 nM, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
CCG-1423
CCG1423
T2014285986-88-1
CCG-1423, a selective RhoA pathway inhibitor, suppresses SRF-mediated transcription.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Phytochelatin 3
PC 3
T8147986220-45-3
Phytochelatin 3 (PC3) is a glutathione-derived peptide and heavy metal detoxifier chelator consisting of 3 units of glu-cys.
  • Inquiry Price
Size
QTY
PX-478
T6961685898-44-6
PX-478 is a HIF-1α inhibitor with selectivity, oral activity, and blood-brain barrier permeability. PX-478 has antitumor activity and also protects pancreatic β-cell function in diabetes mellitus and is used in type 2 diabetes mellitus research.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
fx-11
LDHA Inhibitor FX11
T15362213971-34-7
FX-11 (LDHA Inhibitor FX11) is A potent, selective and competitive specific inhibitor of lactate dehydrogenase A (LDHA) with a Ki of 8 μM. FX-11 can activate PKM2 (pyruvate kinase M2). FX-11 can reduce ATP levels, induce oxidative stress and ROS production, and cause cell death. FX-11 appeared antitumor activity during xenotransplantation of lymphoma and pancreatic cancer.
  • Inquiry Price
14-16 weeks
Size
QTY
TargetMol | Inhibitor Hot
Enzalutamide
MDV3100
T6002915087-33-1
Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist (IC50=36 nM in LNCaP) that activates autophagy, exhibits antitumor activity, and is commonly used in treating desmoplasia-resistant prostate cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Thapsigargin
TQ030267526-95-8
Thapsigargin is a natural product, an inhibitor of sarcoplasmic endoplasmic reticulum Ca2+ ATPase (SERCA) and an endoplasmic reticulum stress inducer. Thapsigargin increases cytoplasmic calcium concentration by blocking the ability of cells to pump calcium into the sarcoplasmic and endoplasmic reticulum.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
TargetMol
Thymectacin
NB1011, NB-1011, NB 1011
T24881232925-18-7In house
Thymectacin (NB 1011) is a selective thymidine synthase (TS) inhibitor with anticancer activity for the study of colon cancer and solid tumors.
  • Inquiry Price
8-10 weeks
Size
QTY
VPC-13163
VPC13163, VPC 13163, NSC52361, NSC 52361, 2,3-dihydro-2,3'-Bi-1H-indole
T291106637-10-1In house
VPC-13163 (NSC-52361) has strong anti-proliferative activity against LNCaP and Enzalutamide-resistant prostate cancer cell lines (MR49F) whereas it did not affect the growth of AR independent PC3 cell line. It also inhibits Prostate Specific Antigen (PSA) in both LNCaP and MR49F and reduces expression of AR target genes, PSA and TMPRSS2. These findings suggest that VPC-13566 exhibits AR BF3 specific mechanism of action.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Cysteine protease inhibitor-2
T10924612048-23-4In house
Cysteine protease inhibitor 2 is a cysteine protease inhibitor. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
  • Inquiry Price
6-8 weeks
Size
QTY
Lovastatin
MK-803, Mevinolin
T120775330-75-5
Lovastatin (MK-803) is an HMG-CoA reductase inhibitor (IC50=3.4 nM). Lovastatin lowers cholesterol and is commonly used as a lipid-lowering agent in the treatment of hypercholesterolemia.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Abacavir
Epzicom, Ziagen
T1267136470-78-5
Abacavir (Ziagen) is a nucleoside reverse transcriptase inhibitor analog of guanosine. This agent decreases HIV viral loads, retards or prevents the damage to the immune system, and reduces the risk of developing AIDS.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
4-Isopropoxybenzaldehyde
ALDH1A3-IN-3
T6434718962-05-5
4-Isopropoxybenzaldehyde (compound 16), a powerful ALDH1A3 inhibitor with an IC50 of 0.26 μM (cell free assay), serves as an effective ALDH3A1 substrate. But shows weak antiproliferative effect against PC3, LNCaP, and DU145 PCa cell lines with IC50>200 μM[1].
  • Inquiry Price
7-10 days
Size
QTY
Hesperetin
T2565520-33-2
Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside hesperidin, is the predominant flavonoid in lemons and oranges.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Adavosertib
MK-1775, AZD1775, Adavosertib (MK-1775)
T2077955365-80-7
Adavosertib (MK-1775) is a small molecule inhibitor of the checkpoint kinase WEE1 (IC50: 5.2 nM). It hinders the G2 DNA damage checkpoint.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
sodium dichloroacetate
Sodium Dichloroacetate, Sodium dichloroacetate (DCA), Sodium bichloroacetic acid, DCA sodium salt
T36042156-56-1
Sodium dichloroacetate (BCA) , a specific inhibitor of pyruvate dehydrogenase kinase (PDK) with IC50 values of 183 and 80 μM for PDK2 and PDK4 respectively, has been shown to derepress a mitochondrial potassium-ion channel axis, trigger apoptosis in cancer cells, and inhibit tumor growth.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited